The IL-1Ra Gene Variable Number Tandem Repeat Variant is Associated with Susceptibility to Temporomandibular Disorders in Turkish Population
Overview
Biotechnology
Pathology
Authors
Affiliations
Background: Temporomandibular joint disorders (TMD) are a group of disorders involving temporomandibular joint and related structures. Interleukine-1 receptor antagonist (IL-1Ra) is an important anti-inflammatory molecule that competes with other interleukin-1 molecules. This study was designed to investigate the possible association of the IL-1Ra VNTR variant with the risk of TMD in the Turkish population.
Methods: Peripheral blood samples were collected from 100 patients with TMD (23 males, 77 females) and 110 healthy individuals (35 males, 75 females). Genotyping of IL-1Ra 86 bp VNTR variant was evaluated by gel electrophoresis after polymerase chain reaction (PCR).
Results: Our results show that there is a statistically significant difference between TMD patients and control group with respect to IL-1Ra genotype distribution and allele frequencies. 1.2, 1.4, and 4.4 genotypes were more common in patients, while 2.2 and 3.3 genotypes were rarer (P<.000). Frequency of alleles 1 and 4 was higher in patient groups (P<.000), whereas alleles 2 and 3 had a lower frequency in patients with TMD (P<.000).
Conclusions: This is the first correlation study that evaluates the association between IL-1Ra gene VNTR variant and TMD. The VNTR variant related to IL-1Ra gene showed a strong pattern of association with TMD that may have a potential impact on disease counseling and management. Larger studies with various ethnicities are needed to establish the impact of IL-1Ra VNTR variant on risk of developing TMD.
Wang Y, Wei H, Hu Y, Niu Y Nat Sci Sleep. 2024; 16:1045-1052.
PMID: 39076457 PMC: 11284133. DOI: 10.2147/NSS.S476277.
Klashami Z, Mostafavi A, Roudbordeh M, Abbasi A, Ebrahimi P, Asadi M Mol Biol Rep. 2023; 50(10):8575-8587.
PMID: 37644369 DOI: 10.1007/s11033-023-08759-w.
Potential pathological and molecular mechanisms of temporomandibular joint osteoarthritis.
Juan Z, Xing-Tong M, Xu Z, Chang-Yi L J Dent Sci. 2023; 18(3):959-971.
PMID: 37404608 PMC: 10316511. DOI: 10.1016/j.jds.2023.04.002.
Altered Plasma Proteins in Myogenous Temporomandibular Disorders.
Ernberg M, Jasim H, Wahlen K, Ghafouri B J Clin Med. 2022; 11(10).
PMID: 35628904 PMC: 9144449. DOI: 10.3390/jcm11102777.
Genetic overlap between temporomandibular disorders and primary headaches: A systematic review.
Cruz D, Monteiro F, Paco M, Vaz-Silva M, Lemos C, Alves-Ferreira M Jpn Dent Sci Rev. 2022; 58:69-88.
PMID: 35242249 PMC: 8881721. DOI: 10.1016/j.jdsr.2022.02.002.